Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The true believers bought common shares not warrants, the people who bought warrants wanted to make money on the cheap (by the way, there is nothing wrong w either approach - just different risk scenarios). Those people who bought warrants are not going to exercise to help out the company.
Is the June warrants the end, are the December warrants, February warrants or next Aprils warrants? That's the question, whichever one it is, the PPS will start to rise after that date. IMO, it's the December warrants.
ok, thanks for doing that calculation for me but I would vote for $12/share in a heartbeat and for someone with 125k shares would get $1,500,000 vs $78,750 today.
warrant holders didn't get fleeced - they just didn't make the right investment, its their own fault
$2 difference b/t dopes and genius - doesn't say much for the geniuses.
Obviously this article was after the new private placement offering - those timelines were changed prior the placement with Shanghai Jugu, it looks like we might see some SPORT action internationally prior to end of 2016 - i guess the longtai deal will tell us. If that gets done, looks like sales by end of 2016 internationally.
HC to make you feel better, I don't just want my money back, however I would like the money sooner rather than later b/c if we don't get a piece of the VERB IPO in a buyout then I want to have as much money as I can to invest in VERB IPO (that stock will be huge in 8 years - similar to ISRG today if not more).
$10/share is the minimum I would take esp prior to a VERB IPO. If VERB IPO's before any M&A activity with Titan that I would hold out for more in PPS.
Uhhmm Titan in their presentation, duh.
Fly, good info and thanks for sharing concrete info. Looks like you are on to something with CMO and ethicon is OEM. I am leaning towards what you are putting out there bc it's uncovered by researching and putting in the time, not just from a "source". Is there any connection w cadence? I noticed the Shift in priorities to surgical robotics by 2020 to generate 50% more revenue. They are obviously connected to a surgical robotics company. I remember about 2 years ago, thru Dundee securities a private placement of Titan stock to someone based in Bedford Mass, isn't that where Novanta is located?
Thanks again for putting specifics to your post on this, gives the board something to research, rather then just chasing speculation and hunches based on sources.
HC give me all the money I invested in Titan and I will vote the way you want me to.
They extended the timelines, IMO, so they could let as many warrants expire as possible. After looking at warrant table, all warrants thru next April will expire, after April the show begins and the stock goes.
Great point, most on this board keep forgetting about the upcoming dates that ISRG's patents expire, will give two hints - 6 and 12 months
It depends if JMAC can tell me that the CMO/OEM begins with the letter N?
I have a source that says the OEM is not jnj or ethicon, my source is JMAC.
JMAC should know.
so you are saying you know who the OEM is?
so your dd is saying they will only have one robot and one platform?
Its reasonable to think that Medtronic/Verb will have multiple platforms for Robotic Surgery - after all that is where all the procedures are heading. To think that they are only going to have one platform would be an incorrect assumption, it is very evident by the recent articles and quotes from Medtronic, Verb and JnJ that they will have multiple platforms - It would be smart for ISRG to expand platforms - we are just so used to seeing just one robotic surgical platform - robotic surgery in 10 years will look so different from what we see today and the Titan SPORT platform will be instrumental in leading that change.
I think ekso is a pumper thing
Zimmer paid $1B for this company ($37/share) - they only did $165M in sales last year.
http://investor.zimmerbiomet.com/releasedetail.cfm?ReleaseID=974589
That's usually outsourced, you sure you're familiar with building an infrastructure?
I'd take $11 - no longer have to work for the "man" at that point. Could sit on a beach and listen to a flamenco guitarist.
Its also naive to think it just has to do with adding sales reps. Infrastructure is so much more than sales personnel - they will need service technicians, clinical liasons, contract personnel, legal, HR, marketing staff, etc. The infrastructure just to support 10-15 sales people generating revenue, especially in a field like surgical robotics would be over 100 - 150 people (that's from previous experience and knowledge of several other surgical device companies). This is not a great example but TRXC had over 100 people in their infrastructure (it might have been closer to 150) prior to commercialization and 3, maybe 4 higher level sales personnel.
So Titan with their $12M in cash (and obvious method of raising funds when needed) is showing no signs of going it alone. They appear to be raising funds to make it to FDA approval then sell. NOW, if they are making progress towards FDA approval and then raise $100-$150M in January 2017 - that might change my view of them going alone but I see zero signs of a company looking to go it alone just signs that they are set up to complete SPORT and sell it along with the IP.
What's amazing about this is that Medtronic is one of the largest medical device companies in the world and Titan will beat them to the market by 2 years. Titan will start selling globally within one year of today (maybe China first or Canada, maybe India) quickly followed by US Sales.
One thing we know is that Titan's milestones don't match up with Medtronic's like they match with JnJ's
great, great point
How about the Ihub Titan page being changed back to the original (2 years ago) format - why all the changes from the info that had been updated on it the last 2 months? That seems odd, that along with the Titan FB page being taken down is weird to say the least and now that there were 2 areas of Titan information now altered tells me something must be up - just not sure if it is good or bad.
Moderators, could you comment on why it was changed back?
sure
That sounds like an uneducated guess
First, IMO Titan has no infrastructure to go it alone and they give no indications of preparing to go it alone. I also don't rule out JNJ bc JNJ has made the Asian Market one of their top priorities from a market growth perspective, along with robotics as a top priority from a revenue growth perspective (per their own quarterly investor reports). Now I see Titan negotiating with longtai and getting a $16m investment from Asia, they are interesting dots to connect.
Imo, that's why jnj will buy Titan.
You are right about Verb, read what they want to do and it's pretty clear that we are right in the crosshairs
Agree
Hmmm, put my future and my family's future on advice from the first chair at the blackjack table, not too sure that's a good idea.
Unless they surprise us with an agreement like Medtronic/Mazor. If that happened, this would shoot up so fast that you wouldn't get them cheap.
You could be right, no one knew about the Mazor/Medtronic Deal until it was announced. Mazors chart even shows that no one knew until after the deal, if they knew before, the stock would have gone up but instead their stock went down until the deal was announced.
I'd vote yes on the first offer (if it was similar to the scenario you laid out). I'd venture to guess that an offer like that would be accepted by a majority of shareholders.
How about Del Prado talking about Voice of Customer feedback in how they are developing their surgical robot.
So HC, the scenario you laid out, if it was the first offer, would you take it?